Myocardial infarction accelerates breast cancer via innate immune reprogramming

心肌梗死通过先天免疫重编程加速乳腺癌的进展

阅读:8
作者:Graeme J Koelwyn ,Alexandra A C Newman ,Milessa S Afonso ,Coen van Solingen ,Emma M Corr ,Emily J Brown ,Kathleen B Albers ,Naoko Yamaguchi ,Deven Narke ,Martin Schlegel ,Monika Sharma ,Lianne C Shanley ,Tessa J Barrett ,Karishma Rahman ,Valeria Mezzano ,Edward A Fisher ,David S Park ,Jonathan D Newman ,Daniela F Quail ,Erik R Nelson ,Bette J Caan ,Lee W Jones ,Kathryn J Moore

Abstract

Disruption of systemic homeostasis by either chronic or acute stressors, such as obesity1 or surgery2, alters cancer pathogenesis. Patients with cancer, particularly those with breast cancer, can be at increased risk of cardiovascular disease due to treatment toxicity and changes in lifestyle behaviors3-5. While elevated risk and incidence of cardiovascular events in breast cancer is well established, whether such events impact cancer pathogenesis is not known. Here we show that myocardial infarction (MI) accelerates breast cancer outgrowth and cancer-specific mortality in mice and humans. In mouse models of breast cancer, MI epigenetically reprogrammed Ly6Chi monocytes in the bone marrow reservoir to an immunosuppressive phenotype that was maintained at the transcriptional level in monocytes in both the circulation and tumor. In parallel, MI increased circulating Ly6Chi monocyte levels and recruitment to tumors and depletion of these cells abrogated MI-induced tumor growth. Furthermore, patients with early-stage breast cancer who experienced cardiovascular events after cancer diagnosis had increased risk of recurrence and cancer-specific death. These preclinical and clinical results demonstrate that MI induces alterations in systemic homeostasis, triggering cross-disease communication that accelerates breast cancer.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。